News & Press Releases

MedTechDive reported that the U.S. Food and Drug Administration is not yet ready to go to Congress to seek new powers for its evolving precertification pilot for software, but it will need new authorities to determine how the experimental path fits into the current regulatory scheme. The article included commentary from Senior Director of ML Strategies Aaron Josephson and Mintz Associate Benjamin Zegarelli.

Mintz Member Stephen Akerley was a featured speaker at the second annual Litigation Finance Dealmakers Forum, held in Manhattan from September 18-19.

An article published by the Boston Globe profiled Mintz Member and Founding Chair of the firm’s Immigration Practice Susan Cohen, highlighting her contributions to federal immigration law and her art that shares refugee stories. As founder of White Dove Productions, Ms. Cohen uses music and music videos to illuminate the plights of immigrants and their vast contributions within the United States.

An article published by Law360 reported that following the U.S. International Trade Commission’s initial decision that Jennewein Biotechnologie GmbH’s imports infringe a Glycosyn LLC patent on human milk oligosaccharides, the Patent Trial and Appeal Board denied Jennewein’s petition for post-grant review of a related patent.

The Mintz team representing Glycosyn at the ITC includes Michael Newman, Thomas Wintner, Michael Renaud and James Wodarski; and the Mintz team representing Glycosyn at the PTAB includes Michael Newman, Thomas Wintner, Peter Cuomo and Daniel Weinger.